Search Result |
Top |
| Entry | Name | Name(TN) | Disease |
|---|---|---|---|
| D00386 | Triamterene (JP18/USP/INN) | Dyrenium (TN) | Nephrotic syndrome [DS:H01657] |
| D02168 |
Topotecan hydrochloride (USAN) Nogitecan hydrochloride (JAN) |
Hycamtin (TN) Potactasol (TN) |
Small cell lung cancer [DS:H00013] Ovarian cancer [DS:H00027] Cervical cancer [DS:H00030] |
| D07453 | Amtolmetin guacil (INN) | Artromed (TN) | |
| D08618 | Topotecan (BAN) | Hycamtin (TN) | |
| D09648 | Omecamtiv mecarbil (USAN/INN) | ||
| D10269 | Hydrochlorothiazide and triamterene | Dyazide (TN) | Hypertension [DS:H01633] |
| D10291 | Aliskiren hemifumarate, amlodipine besylate and hydrochlorothiazide | Amturnide (TN) | |
| D11659 | Tolvaptan sodium phosphate (JAN) | Samtasu (TN) | |
| D11701 |
Luspatercept (USAN/INN) Luspatercept (genetical recombination) (JAN) Luspatercept-aamt |
Reblozyl (TN) | beta Thalassemia [DS:H00228] |
| D11809 | Omecamtiv mecarbil hydrochloride hydrate (JAN) | ||
| D11824 | Danicamtiv (USAN/INN) | ||
| D11971 |
Tozinameran (JAN) COVID-19 mRNA vaccine (nucleoside-modified) Tozinameran and riltozinameran Tozinameran and famtozinameran Tozinameran and raxtozinameran |
Comirnaty (TN) Pfizer-biontech Covid-19 vaccine (TN) |
Prevention of COVID-19 [DS:H02398] |
| D12253 | Aficamten (USAN/INN) | ||
| D12265 | Mavacamten (JAN/USAN/INN) | Camzyos (TN) | Hypertrophic cardiomyopathy [DS:H00292] |
| D12569 |
Apadamtase alfa (INN) Apadamtase alfa (genetical recombination) (JAN) |
||
| D12570 |
Cinaxadamtase alfa (INN) Cinaxadamtase alfa (genetical recombination) (JAN) |
||
| D12833 | Lifileucel (USAN/INN) | Amtagvi (TN) | Melanoma (BRAF V600 mutation positive) [DS:H00038] |
| D12835 |
Recombinant ADAMTS13 Apadamtase alfa (genetical recombination) and cinaxadamtase alfa (genetical recombination) ADAMTS13, recombinant-krhn |
Adzynma (TN) | Congenital thrombotic thrombocytopenic purpura [DS:H00225] |
| D12862 | Noraramtide (USAN) | ||
| D12899 | Zidesamtinib (USAN/INN) |
| [ KEGG | DISEASE | DRUG | MEDICUS ] |